Table 3 Study characteristics of included observational studies
Study | Study Design | Study Period | Country | Type of influenza vaccine |
|---|---|---|---|---|
Huang et al. 2013 | SCCS | 2009–2010 | Taiwan | monovalent MF59H adjuvanted vaccine /monovalent inactivated vaccine without adjuvant |
Moro et al. 2013 | Cohort | 2009–2010 | Italy | MF59-adjuvanted A/H1N1 influenza vaccine, Focetria®(Novartis Vaccines & Diagnostics, Siena, Italy) |
O’Leary et al. 2011 | SCCS | 2000–2009 | US | TIV |
Woo et al. 2011 | Cross sectional | 1990–2008. | US | Live intranasal trivalent influenza virus |
US | Trivalent inactivated influenza virus vaccine (FLU) | |||
Grimaldi-Bensouda et al. 2012 | Case control | 2008–2011 | France | injectable/killed type |
Isai et al. 2012 | Cross sectional | 2009–2010 | European union | Adjuvanted (CelturaTM, Fluval PTM, FocetriaTM, PandemrixTM) |
Lafaurie et al. 2022 | SCCS | 2009–2018 | France | Influenza vaccine |
Huand et al. 2012 | Cross sectional | 2009–2010 | Taiwan | H1N1 Vaccine |
Nakayama et al. 2007 | Cross sectional | 1994:2004 | Japan | monovalent inactivated vaccine |
Yokomichi et al. 2020 | Case control | till 2019 | Japan | NR |
Clayes et al. 2018. | RCT | 2011–2012 | Belgium, Czech, Republic, Poland, Spain, United Kingdom | A/H1N1: California/7/2009§ A/H3N2: Victoria/210/2009 B Victoria: Brisbane/60/2008 B Yamagata: Brisbane/3/2007 |
April 9, 2012 – Dec 12, 2012* | Bangladesh, Dominican Republic, Honduras | A/H1N1: California/7/2009§ A/H3N2: Victoria/210/2009 B Victoria: Brisbane/60/2008 B Yamagata: Hubei-Wujiagang/158/2009 | ||
2012–2013 | Belgium, Czech Republic, Lebanon, Poland, Spain, Turkey, UK | A/H1N1: Christchurch/16/2010§ A/H3N2: Victoria/361/2011 B Victoria: Brisbane/60/2008 B Yamagata: Hubei-Wujiagang/158/2009 | ||
March 7, 2013 – Dec 2, 2013* | Bangladesh, Dominican Republic, Honduras, Philippines, Thailand | A/H1N1: Christchurch/16/2010§ A/H3N2: Victoria/361/2011 B Victoria: Brisbane/60/2008 B Yamagata: Hubei-Wujiagang/158/2009 | ||
March 11, 2014 – Dec 31, 2014* | Bangladesh, Dominican Republic, Honduras, India, Philippines, Thailand | A/H1N1: Christchurch/16/2010§ A/H3N2: Texas/50/2012 B Victoria: Brisbane/60/2008 B Yamagata: Massachusetts/2/2012 | ||
Haber et al. 2015 | Cross sectional | 2013:2014 | United States of America | LAIV4/LAIV3 |
Villa et al. 2013 | Cohort | 3 years | Italy | LAIV3 |